Iridex Corp
IRIX- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001006045
In the last 90 days, Iridex Corp insiders filed 4 open-market purchases and 0 sales; 29 institutions reported holding it in 13F filings for Q2 2026, worth $2.47M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Iridex Corp as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +2 vs. Q3 2025
- Shares held
- 2.79M
- +239.5K (+9.4%) vs. Q3 2025
- Total value
- $3.19M
- +$269.1K (+9.2%) vs. Q3 2025
- New holders
- 4
- 3 more added
- Sold out
- 2
- 7 more reduced
2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IRIX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $2.47M |
| Q1 2026 | 25 | $2.92M |
| Q4 2025 | 22 | $3.19M |
| Q3 2025 | 22 | $3.24M |
| Q2 2025 | 20 | $2.37M |
| Q1 2025 | 24 | $3.19M |
| Q4 2024 | 27 | $5.43M |
| Q3 2024 | 28 | $5.83M |
| Q2 2024 | 29 | $7.08M |
| Q1 2024 | 30 | $9.90M |
| Q4 2023 | 32 | $9.17M |
| Q3 2023 | 31 | $9.03M |
| Q2 2023 | 28 | $8.43M |
| Q1 2023 | 31 | $7.56M |
| Q4 2022 | 26 | $7.23M |
| Q3 2022 | 28 | $8.51M |
| Q2 2022 | 30 | $9.07M |
| Q1 2022 | 32 | $17.0M |
| Q4 2021 | 32 | $21.4M |
| Q3 2021 | 29 | $26.8M |
| Q2 2021 | 33 | $27.2M |
| Q1 2021 | 29 | $26.0M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Iridex Corp; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Paragon Associates & Paragon Associates II Joint Venture | 1,000,000 | $1.14M | 2.36% | 00.0% | Unchanged |
| Vanguard Group Inc | 578,711 | $659.7K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 371,560 | $423.6K | 0.00% | −17,500−4.5% | Reduced |
| Weber Capital Management LLC | 259,558 | $295.9K | 0.28% | +259,558 | New |
| Geode Capital Management, LLC | 135,208 | $154.2K | 0.00% | +2,149+1.6% | Added |
| United Capital Financial Advisers, LLC | 65,529 | $74.7K | 0.00% | +65,529 | New |
| State Street Corp | 44,718 | $51.0K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 41,385 | $47.2K | 0.00% | −6,408−13.4% | Reduced |
| Perkins Capital Management Inc | 41,300 | $47.1K | 0.04% | 00.0% | Unchanged |
| Citadel Advisors LLC | 34,395 | $39.2K | 0.00% | −75,078−68.6% | Reduced |
| Jane Street Group, LLC | 31,758 | $36.2K | 0.00% | +15,377+93.9% | Added |
| Bank of New York Mellon Corp | 31,540 | $36.0K | 0.00% | 00.0% | Unchanged |
| Thompson Davis & Co., Inc. | 28,500 | $32.5K | 0.02% | +28,500 | New |
| XTX Topco Ltd | 28,494 | $32.5K | 0.00% | +2,094+7.9% | Added |
| Susquehanna International Group, LLP | 24,487 | $27.9K | 0.00% | −31,983−56.6% | Reduced |
| Diversify Advisory Services, LLC | 19,134 | $27.0K | 0.00% | +19,134 | New |
| Northern Trust Corp | 21,308 | $24.3K | 0.00% | −1,951−8.4% | Reduced |
| BlackRock, Inc. | 20,260 | $23.1K | 0.00% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 10,000 | $11.4K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 1,100 | $1.25K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 580 | $661 | 0.00% | −179−23.6% | Reduced |
| Bank of America Corp | 127 | $144 | 0.00% | −495−79.6% | Reduced |
| Centiva Capital, LP | 0 | $0 | 0.00% | −18,768−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −501−100.0% | Sold out |
| AMH Equity Ltd | – | – | – | – | Not filed |
| Apexium Financial, LP | – | – | – | – | Not filed |